Abstract
While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 647-649 |
| Number of pages | 3 |
| Journal | Radiology |
| Volume | 242 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2007 |
| Externally published | Yes |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS